Waiting
Processando Login

Trial ends in Request Full Access Tell Your Colleague About Jove
Journal / Immunology and Infection / Oral kombinationsmæssig antiretroviral behandling …
JoVE Journal
Immunology and Infection

É necessário ter uma assinatura JoVE para assistir este Faça login ou comece sua avaliação gratuita.

JoVE Journal Immunology and Infection
Oral kombinationsmæssig antiretroviral behandling i HIV-1-inficerede humaniserede mus
Nitrotetrazolium Blue Chloride (NBT) Assay for Evaluating ROS Production (Video) | JoVE
Journal (Immunology and Infection)
Nitrotetrazolium Blue Chloride (NBT) Assay for Evaluating ROS Production (Video) | JoVE
Analysis of HBV-Specific CD4 T-cell Responses and Identification of HLA-DR-Restricted CD4 T-Cell Epitopes Based on a Peptide Matrix
Journal (Immunology and Infection)
Analysis of HBV-Specific CD4 T-cell Responses and Identification of HLA-DR-Restricted CD4 T-Cell Epitopes Based on a Peptide Matrix
 
Click here for the English version

Oral kombinationsmæssig antiretroviral behandling i HIV-1-inficerede humaniserede mus

Article DOI: 10.3791/63696-v • 06:07 min • October 6th, 2022
October 6th, 2022 •
1, 1, 1, 1, 1, 1, 1
1Division of Hematology and Oncology, David Geffen School of Medicine, University of California, Los Angeles

Capítulos

Resumo
Automatic Translation

Please note that all translations are automatically generated.

Click here for the English version.

Denne protokol beskriver en ny metode til at levere orale kombinationsmæssige antiretrovirale lægemidler, der med succes undertrykker HIV-1 RNA-replikation i humaniserede mus.

Tags

Immunologi og infektion udgave 188
Read Article

Get cutting-edge science videos from JoVE sent straight to your inbox every month.

Waiting X
Simple Hit Counter